Aura Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Aura Biosciences Total Assets Growth & History (AURA)
Aura Biosciences's total assets was $169.4M for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $169.4M | −$13.1M | −7.16% |
| 2024 | 2024-12-31 | $182.5M | −$72.6M | −28.45% |
| 2023 | 2023-12-31 | $255.1M | $31.1M | +13.91% |
| 2022 | 2022-12-31 | $223.9M | $63.9M | +39.93% |
| 2021 | 2021-12-31 | $160.0M | $137.9M | +623.99% |
| 2020 | 2020-12-31 | $22.1M | — | — |
Aura Biosciences quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $348.1M | $143.7M | +70.32% |
| Q1 2026 | 2026-03-31 | $137.7M | −$17.7M | −11.41% |
| Q4 2025 | 2025-12-31 | $169.4M | −$13.1M | −7.16% |
| Q3 2025 | 2025-09-30 | $190.0M | −$15.3M | −7.46% |
| Q2 2025 | 2025-06-30 | $204.4M | −$13.9M | −6.36% |
| Q1 2025 | 2025-03-31 | $155.4M | −$79.6M | −33.88% |
| Q4 2024 | 2024-12-31 | $182.5M | −$72.6M | −28.45% |
| Q3 2024 | 2024-09-30 | $205.3M | $25.6M | +14.23% |
| Q2 2024 | 2024-06-30 | $218.3M | $25.5M | +13.25% |
| Q1 2024 | 2024-03-31 | $235.0M | $29.0M | +14.08% |
| Q4 2023 | 2023-12-31 | $255.1M | $31.1M | +13.91% |
| Q3 2023 | 2023-09-30 | $179.8M | $36.6M | +25.58% |
| Q2 2023 | 2023-06-30 | $192.7M | $57.7M | +42.75% |
| Q1 2023 | 2023-03-31 | $206.0M | $59.6M | +40.70% |
| Q4 2022 | 2022-12-31 | $223.9M | $63.9M | +39.93% |
| Q3 2022 | 2022-09-30 | $143.1M | $52.4M | +57.82% |
| Q2 2022 | 2022-06-30 | $135.0M | — | — |
| Q1 2022 | 2022-03-31 | $146.4M | — | — |
| Q4 2021 | 2021-12-31 | $160.0M | $137.9M | +623.99% |
| Q3 2021 | 2021-09-30 | $90.7M | — | — |
| Q4 2020 | 2020-12-31 | $22.1M | — | — |
Aura Biosciences total assets trends
Over the last five fiscal years, Aura Biosciences's total assets increased from $22.1M to $169.4M, a change of $147.3M. The latest reported quarter, Q2 2026, shows $348.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗